Table 1.
Demographic characteristics and results of the univariate analysis of patients with HCC.
| Variables | Bile duct injury (n=63) | No bile duct injury (n=221) | T/χ2/Z value | P value |
|---|---|---|---|---|
| Gender | ||||
| Males/Females | 43/20 | 145/76 | 0.153 | 0.409 |
| Age | 54.67 ± 11.94 | 53.13 ± 14.34 | 0.778 | 0.025 |
| Liver disease background | ||||
| HBV/HCV/Alcohol/Others | 48/7/6/2 | 173/24/15/9 | 0.629 | 0.787 |
| History of hepatectomy | ||||
| Yes/No | 16/47 | 30/191 | 5.048 | 0.023 |
| TACE number | 2.86 ± 1.28 | 2.81 ± 1.27 | 0.221 | 0.591 |
| TACE interval time(d) | 40.57 ± 8.68 | 40.64 ± 8.051 | 0.061 | 0.333 |
| Tumor number | 2.75 ± 1.98 | 3.19 ± 2.32 | 1.396 | 0.069 |
| Tumor diameter(mm) | 56.16 ± 31.51 | 61.37 ± 33.82 | 1.905 | 0.285 |
| Tumor burden(6-12 score) | 8.41 ± 3.51 | 9.43 ± 3.91 | 1.870 | 0.191 |
| Tumor burden group | ||||
| ≤6/6-12/≥12 | 19/34/10 | 62/98/61 | 4.862 | 0.028 |
| BCLC stage | ||||
| A/B | 33/30 | 103/108 | 0.655 | 0.252 |
| CP class | ||||
| A/B | 48/15 | 147/74 | 2.133 | 0.094 |
| SACE level | ||||
| I/II/III/IV | 5/9/30/19 | 27/90/76/28 | 21.987 | 0.000 |
| Bead diameter(µm) | ||||
| 70-150/100-300/300-500 | 20/33/10 | 42/130/49 | 4.937 | 0.041 |
| ALT | 51.19 ± 45.75 | 53.45 ± 47.09 | 0.338 | 0.736 |
| ASL | 69.94 ± 57.77 | 59.32 ± 51.12 | 1.412 | 0.159 |
| AKP | 182.24 ± 140.75 | 129.26 ± 70.73 | 4.082 | 0.000 |
| GGTP | 215.87 ± 280.62 | 147.18 ± 128.96 | 2.764 | 0.006 |
| ALB | 35.64 ± 4.99 | 34.871 ± 5.27 | 1.032 | 0.303 |
| TBil | 30.07 ± 39.34 | 27.23 ± 31.77 | 0.590 | 0.555 |
| DBil | 17.82 ± 30.82 | 15.66 ± 25.48 | 0.567 | 0.571 |
| PLT | 164.38 ± 92.85 | 129.76 ± 82.15 | 2.865 | 0.004 |
| PT | 13.05 ± 1.59 | 13.305 ± 1.55 | 1.124 | 0.262 |
| PT extension time | 1.17 ± 1.55 | 1.442 ± 1.65 | 1.163 | 0.246 |
CP, Child-Pugh score; HBV, hepatitis B virus; HCV, hepatitis C virus.